Stocksigma LogoStocksigma Logo

Aarti Drugs Updates Authorized Key Management Personnel for Materiality Disclosures

Pursuant to Regulation 30(5) of SEBI LODR Regulations and following Directorate and Management changes, Aarti Drugs Limited updated its authorized

Aarti Drugs Updates Authorized Key Management Personnel for Materiality Disclosures

Aarti Drugs Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 12:38 am

Aarti Drugs Updates Authorized Key Management Personnel for Materiality Disclosures Pursuant to Regulation 30(5) of SEBI LODR Regulations and following Directorate and Management changes, Aarti Drugs Limited updated its authorized personnel effective 1st Oct'26. Managing Director Adhish P. Patil and Joint Managing Director Harshit M. Savla are authorized to determine event materiality and make stock exchange disclosures. Additionally, Company Secretary and Compliance Officer Rushikesh V. Deole is authorized to execute disclosures to stock exchanges.

Original exchange filing (PDF)

More announcements from Aarti Drugs Ltd

All Aarti Drugs Ltd announcements